Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques

Michael Schäfers1, Otmar Schober, Sven Hermann

  • 1European Institute for Molecular Imaging-EIMI, Münster, Germany. schafmi@uni-muenster.de

Insights

New imaging techniques targeting matrix-metalloproteinases (MMPs) show promise for assessing cardiovascular event risk. Visualizing inflammation in blood vessels could personalize prevention strategies for myocardial infarction and stroke.

Area of Science:

  • Biomedical imaging
  • Cardiovascular research
  • Molecular imaging

Background:

  • Atherosclerosis underlies most global deaths from myocardial infarction and stroke.
  • Inflammation in vessel walls is a key factor in plaque progression and rupture.
  • Current risk assessment for cardiovascular events has limitations.

Purpose of the Study:

  • To review the clinical rationale for imaging matrix-metalloproteinases (MMPs).
  • To discuss the potential of MMP-targeted imaging for cardiovascular risk stratification.
  • To summarize the current status of MMP imaging in the context of stroke and myocardial infarction.

Main Methods:

  • Review of existing literature on MMPs in atherosclerosis.
  • Analysis of imaging strategies targeting MMPs.
  • Clinical perspective on the application of MMP imaging.

Main Results:

  • Matrix-metalloproteinases (MMPs) play a critical role in plaque vulnerability.
  • Targeting MMPs offers a promising avenue for molecular imaging of atherosclerotic disease.
  • Imaging MMPs could enable earlier detection and personalized prevention of cardiovascular events.

Conclusions:

  • MMP-targeted imaging represents a significant advancement in cardiovascular diagnostics.
  • This approach has the potential to improve individualized risk assessment for myocardial infarction and stroke.
  • Further clinical translation of MMP imaging is warranted to realize its full potential in preventing cardiovascular mortality.